ES2149448T3 - Agentes terapeuticos y analiticos. - Google Patents

Agentes terapeuticos y analiticos.

Info

Publication number
ES2149448T3
ES2149448T3 ES96901878T ES96901878T ES2149448T3 ES 2149448 T3 ES2149448 T3 ES 2149448T3 ES 96901878 T ES96901878 T ES 96901878T ES 96901878 T ES96901878 T ES 96901878T ES 2149448 T3 ES2149448 T3 ES 2149448T3
Authority
ES
Spain
Prior art keywords
therapeutic
analytical agents
analytical
agents
oxoquanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96901878T
Other languages
English (en)
Inventor
Sian Myra Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leicester
Original Assignee
University of Leicester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leicester filed Critical University of Leicester
Application granted granted Critical
Publication of ES2149448T3 publication Critical patent/ES2149448T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A AGENTES PARA SU UTILIZACION EN UN METODO DE DETECCION DE 8 GUANOSINA, 8 ERA DE 8 8 -OXODESOXIADENOSINA, JUNTO CON METODOS PARA LA DETECCION DE BASES DE ACIDO NUCLEICO DAÑADAS.
ES96901878T 1995-05-31 1996-02-05 Agentes terapeuticos y analiticos. Expired - Lifetime ES2149448T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510954.2A GB9510954D0 (en) 1995-05-31 1995-05-31 Detection of DNA damage

Publications (1)

Publication Number Publication Date
ES2149448T3 true ES2149448T3 (es) 2000-11-01

Family

ID=10775254

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96901878T Expired - Lifetime ES2149448T3 (es) 1995-05-31 1996-02-05 Agentes terapeuticos y analiticos.

Country Status (10)

Country Link
US (1) US6309825B1 (es)
EP (1) EP0828854B1 (es)
JP (1) JP3510267B2 (es)
AT (1) ATE193560T1 (es)
AU (1) AU704928B2 (es)
CA (1) CA2222513C (es)
DE (1) DE69608683T2 (es)
ES (1) ES2149448T3 (es)
GB (1) GB9510954D0 (es)
WO (1) WO1996038588A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011371A1 (en) 1995-09-19 1997-03-27 Cytochem, Inc. Detection and quantitation of 8-oh-adenine using monoclonal antibodies
WO2002065889A1 (de) * 2001-02-21 2002-08-29 Rubikon Ag Verfahren zur untersuchung von zell- und gewebeproben
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
JP2010539085A (ja) 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのキバナオウギのエストロゲン性抽出物およびその使用
EP2219659A4 (en) 2007-11-19 2010-11-17 Bionovo Inc METHODS OF DETECTION AND TREATMENT OF CANCERS USING BARBATA SCUTTELARIA EXTRACT
CA2706330A1 (en) 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
US8580516B2 (en) * 2008-09-05 2013-11-12 University Of Chicago Methods and compositions for direct detection of DNA damage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015707A1 (en) * 1991-02-27 1992-09-17 New York University Immunoassay for antibodies to oxidized dna and uses thereof

Also Published As

Publication number Publication date
GB9510954D0 (en) 1995-07-26
CA2222513C (en) 2009-10-13
EP0828854B1 (en) 2000-05-31
WO1996038588A1 (en) 1996-12-05
CA2222513A1 (en) 1996-12-05
AU4627896A (en) 1996-12-18
ATE193560T1 (de) 2000-06-15
DE69608683T2 (de) 2001-02-08
JP3510267B2 (ja) 2004-03-22
JPH11507435A (ja) 1999-06-29
US6309825B1 (en) 2001-10-30
EP0828854A1 (en) 1998-03-18
AU704928B2 (en) 1999-05-06
DE69608683D1 (de) 2000-07-06

Similar Documents

Publication Publication Date Title
ES2178093T3 (es) Derivados de epotilon y su preparacion.
FI964339L (fi) Glukaanien entsyymikäsittely
NO982055D0 (no) 2-alkylpyrrolidiner
LV11986A (lv) Rotamazes fermenta aktivitates inhibitori
HN1996000017A (es) Isotiazolonas
TR199600516A2 (tr) Kakaonun enzimatik muamelesi.
DE69512491D1 (de) Aktives Führungssystem eines Aufzuges
AU4612596A (en) Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore
TR199802441A3 (tr) Kanda asiri ürik asit bulunmasinin tedavisi ve önlenmesi için yöntem ve terkip.
ATE203519T1 (de) Chinolinderivate als antimalariamittel
EP0883809A4 (en) METHOD FOR DIAGNOSTIC PROSTATE ADENOCARCINOMAS
FI971802A7 (fi) Mycobacterium avium-kompleksilajien monistus ja ilmaisu
EP1011718A4 (en) ANTI-VIRAL TREATMENT WITH PERTUSSIS TOXIN B OLIGOMER
ES2149448T3 (es) Agentes terapeuticos y analiticos.
BR9602884A (pt) Subconjunto de freio de atrito e método de fabricar o mesmo
BG102064A (en) Method for increasing the retinal blood circulation
DE69611783D1 (de) Benzisoxazol- und indazol- derivate als antipsychotika
EP0998578A4 (en) SEL-10 AND ITS USES
NO20011901L (no) Antikonvulsive derivater nyttige ved behandling av alkoholavhengighet og -misbruk
DE59608611D1 (de) Topische aciclovir-zubereitung
ITBO970498A0 (it) Metodo di rullatura di spezzoni di sigaretta.
BR9608978A (pt) Inibidor de protease de serina derivado de imidazo [1,5a] piridina composição farmacêutica e utilização do inibidor de protease
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
ES2186782T3 (es) Uso de derivados de tropolona como inhibidores de la enzima inositol-monofosfatasa.
BR9610540A (pt) Determinação de microorganismos não-parafinofílicos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 828854

Country of ref document: ES